another new "glitazone" for type 2 diabetes, Actos (pioglitazone)
You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone)...co-marketed by Lilly and Takeda.
This is the third one...after Avandia (rosiglitazone) and Rezulin (troglitazone).
All three lower blood glucose by improving insulin sensitivity.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote